Anke Reinacher‐Schick

7.8k total citations · 1 hit paper
158 papers, 4.7k citations indexed

About

Anke Reinacher‐Schick is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Anke Reinacher‐Schick has authored 158 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Oncology, 60 papers in Pulmonary and Respiratory Medicine and 37 papers in Cancer Research. Recurrent topics in Anke Reinacher‐Schick's work include Colorectal Cancer Treatments and Studies (63 papers), Pancreatic and Hepatic Oncology Research (35 papers) and Cancer Genomics and Diagnostics (35 papers). Anke Reinacher‐Schick is often cited by papers focused on Colorectal Cancer Treatments and Studies (63 papers), Pancreatic and Hepatic Oncology Research (35 papers) and Cancer Genomics and Diagnostics (35 papers). Anke Reinacher‐Schick collaborates with scholars based in Germany, United States and France. Anke Reinacher‐Schick's co-authors include Wolff Schmiegel, Hana Algül, Dirk Arnold, Daniel Hochhauser, Giampaolo Tortora, Teresa Macarulla, Michele Reni, Hedy L. Kindler, Do‐Youn Oh and Eileen M. O’Reilly and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Anke Reinacher‐Schick

146 papers receiving 4.6k citations

Hit Papers

Maintenance Olaparib for Germline BRCA -Mutated Metastati... 2019 2026 2021 2023 2019 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
    2019 1.5k citations Talia Golan, Pascal Hammel et al. New England Journal of Medicine profile →

Peers

Anke Reinacher‐Schick
Hagen F. Kennecke Canada
Michael J. Pishvaian United States
Eduardo Vilar United States
Andrea Rocca Italy
Nilofer S. Azad United States
E. Gabriela Chiorean United States
Andrew Kramar France
Young Suk Park South Korea
Élena Elez Spain
Rona Yaeger United States
Hagen F. Kennecke Canada
Anke Reinacher‐Schick
Citations per year, relative to Anke Reinacher‐Schick Anke Reinacher‐Schick (= 1×) peers Hagen F. Kennecke

Countries citing papers authored by Anke Reinacher‐Schick

Since Specialization
Citations

This map shows the geographic impact of Anke Reinacher‐Schick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Reinacher‐Schick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Reinacher‐Schick more than expected).

Fields of papers citing papers by Anke Reinacher‐Schick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Reinacher‐Schick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Reinacher‐Schick. The network helps show where Anke Reinacher‐Schick may publish in the future.

Co-authorship network of co-authors of Anke Reinacher‐Schick

This figure shows the co-authorship network connecting the top 25 collaborators of Anke Reinacher‐Schick. A scholar is included among the top collaborators of Anke Reinacher‐Schick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Reinacher‐Schick. Anke Reinacher‐Schick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ballhausen, Alexej, David Horst, Ullrich Graeven, et al.. (2025). Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for RAS wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial. Clinical Cancer Research. 31(19). 4049–4058. 1 indexed citations
2.
3.
Gambichler, Thilo, Marina Skrygan, Laura Susok, et al.. (2024). A Prospective Study Investigating Immune Checkpoint Molecule and CD39 Expression on Peripheral Blood Cells for the Prognostication of COVID-19 Severity and Mortality. Viruses. 16(5). 810–810. 2 indexed citations
4.
Ekmekçiu, Ira, Bülent Sargin, Stephan Hollerbach, et al.. (2024). Exploring the molecular profile of localized colon cancer: insights from the AIO Colopredict Plus registry. Frontiers in Oncology. 14. 1434791–1434791. 1 indexed citations
5.
Tamaskovics, Bálint, Markus Hecht, Philipp Schubert, et al.. (2023). 944TiP Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial. Annals of Oncology. 34. S593–S593. 1 indexed citations
6.
Gerwert, Klaus, Frederik Großerueschkamp, Inke Sabine Feder, et al.. (2023). Fast and label-free automated detection of microsatellite status in early colon cancer using artificial intelligence integrated infrared imaging. European Journal of Cancer. 182. 122–131. 18 indexed citations
7.
8.
Stintzing, Sebastian, Kathrin Heinrich, David Tougeron, et al.. (2023). FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study. Journal of Clinical Oncology. 41(25). 4143–4153. 32 indexed citations
9.
Fendler, Wolfgang P., Kim M. Pabst, Rainer Hamacher, et al.. (2023). 68Ga-FAPI-46 PET for cancer imaging: A prospective single-arm clinical trial.. Journal of Clinical Oncology. 41(16_suppl). 3064–3064. 1 indexed citations
10.
Schoffer, Olaf, Patrick Jahn, Patrick Michl, et al.. (2023). Mental burden and moral distress among oncologists and oncology nurses in Germany during the third wave of the COVID-19 pandemic: a cross-sectional survey. Journal of Cancer Research and Clinical Oncology. 149(9). 6211–6223. 8 indexed citations
11.
Kindler, Hedy L., Pascal Hammel, Michele Reni, et al.. (2022). Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer. Journal of Clinical Oncology. 40(34). 3929–3939. 120 indexed citations
12.
Reinacher‐Schick, Anke, et al.. (2022). Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice. Oncology Research and Treatment. 45(12). 752–763. 1 indexed citations
13.
Plaza‐Sirvent, Carlos, Jaydeep Bhat, Doris Urlaub, et al.. (2022). Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV. Frontiers in Immunology. 13. 1049070–1049070. 11 indexed citations
14.
Seufferlein, Thomas, Waldemar Uhl, Hana Algül, et al.. (2021). LBA56 Perioperative or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Results of the NEONAX trial, a randomized phase II AIO study. Annals of Oncology. 32. S1333–S1333. 5 indexed citations
15.
Conradi, Lena‐Christin, et al.. (2021). Einfluss der Molekularpathologie auf die onkologische Chirurgie des kolorektalen Karzinoms. Der Chirurg. 92(11). 986–995. 3 indexed citations
16.
Golan, Talia, Pascal Hammel, Michele Reni, et al.. (2019). Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer. New England Journal of Medicine. 381(4). 317–327. 1468 indexed citations breakdown →
17.
Hammel, P., Hedy L. Kindler, Michele Reni, et al.. (2019). Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib. Annals of Oncology. 30(12). 1959–1968. 33 indexed citations
18.
Pitarokoili, Kalliopi, Anke Reinacher‐Schick, Min‐Suk Yoon, & Ralf Gold. (2015). Bortezomib - new option for aggressive chronic inflammatory demyelinating polyradiculoneuritis (P3.188). Neurology. 84(14_supplement). 1 indexed citations
19.
El‐Mashtoly, Samir F., Dennis R. Petersen, Hesham K. Yosef, et al.. (2013). Label-free imaging of drug distribution and metabolism in colon cancer cells by Raman microscopy. The Analyst. 139(5). 1155–1155. 123 indexed citations
20.
Schulmann, Karsten, Stephan Hollerbach, Jörg Willert, et al.. (2005). Feasibility and Diagnostic Utility of Video Capsule Endoscopy for the Detection of Small Bowel Polyps in Patients with Hereditary Polyposis Syndromes. The American Journal of Gastroenterology. 100(1). 27–37. 171 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hagen F. Kennecke Breakdown of academic impact, for papers by Michael J. Pishvaian Breakdown of academic impact, for papers by Eduardo Vilar Breakdown of academic impact, for papers by Andrea Rocca Breakdown of academic impact, for papers by Nilofer S. Azad Breakdown of academic impact, for papers by E. Gabriela Chiorean Breakdown of academic impact, for papers by Andrew Kramar Breakdown of academic impact, for papers by Young Suk Park Breakdown of academic impact, for papers by Élena Elez Breakdown of academic impact, for papers by Rona Yaeger
Rankless by CCL
2026